Your reference journal for coronary, valvular and structural interventions

Articles

Research Correspondence

10.4244/EIJ-D-25-00068 • Jul 21, 2025

Intracoronary nicardipine to induce hyperaemia

Viscusi M, Seki R, Leone A, Bertolone D, Mizukami T, Mahendiran T, Belmonte M, Sonck J, Collet C, De Bruyne B

Flashlight

10.4244/EIJ-D-24-00461 • Jul 21, 2025

The heterogeneity of response to direct oral anticoagulants in patients with hypoattenuating leaflet thickening

Husain A, Jelisejevas J, Khoo J, Althekrallah J, Tregobov N, Offen S, Millar K, Leipsic J, Meier D, Sellers S, Webb J

EAPCI Column

Jul 21, 2025

EAPCI focus on the Online Educational Initiatives

free

Snapshot

Jul 21, 2025

State-of-the-Art review on the imaging of atherosclerotic plaques; low-dose prasugrel monotherapy in acute coronary syndrome; supersaturated oxygen therapy in acute anterior myocardial infarction; resting pullback pressure gradient; nicardipine and coronary hyperaemia; anticoagulation for HALT; the potential of factor XI inhibition; news from EAPCI; and more

free

Editorial

10.4244/EIJ-E-25-00023 • Jul 21, 2025

DAPT de-escalation post-ACS: a new rule or just a new option? Lessons from the 4D-ACS trial

Cuisset T, Cayla G

free

Editorial

10.4244/EIJ-E-25-00031 • Jul 21, 2025

Supersaturated oxygen therapy to reduce myocardial infarct size: time to pay attention!

Stone G, Akinmolayemi O

free

Viewpoint

10.4244/EIJ-D-24-00943 • Jul 21, 2025

Factor XI inhibition for ACS patients: premises and prospects

Lopes R, Fanaroff A

free

State-of-the-Art

10.4244/EIJ-D-24-00387 • Jul 21, 2025

Advances in coronary imaging of atherosclerotic plaques

Garcia-Garcia H, Sanz-Sánchez J, Pinilla-Echeverri N, Blanco P, Bourantas C, Alfonso F

free

Original Research

10.4244/EIJ-D-25-00331 • Jul 21, 2025

One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial

Jang Y, Park S-D, Lee JP, Choi SH, Kong MG, Won YS, Kim M, Lee KH, Han SH, Kwon SW, Suh J, Kang WC

open access

Snapshot

Jul 7, 2025

Robotics in structural heart interventions; debating colchicine recommendations; the AUREA trial; intra- vs supra-annular self-expanding valves in small aortic annuli; Myval durability at 4 years; restenosis patterns after drug-coated balloon PCI; news from the EAPCI; and more...

free

Editorial

10.4244/EIJ-E-25-00027 • Jul 7, 2025

Antithrombotic strategies after TAVI in light of cerebral microembolism

Dangas G, Nicolas J

free

Editorial

10.4244/EIJ-E-25-00028 • Jul 7, 2025

The challenge of interpreting comparative TAVI studies

Rosseel L, Khokhar A, De Backer O

free

Editorial

10.4244/EIJ-E-25-00024 • Jul 7, 2025

The new balloon-expandable Myval transcatheter heart valve: only good news?

Pibarot P, Van Belle E

free

Debate

10.4244/EIJ-E-25-00019 • Jul 7, 2025

Colchicine benefits are overestimated and current recommendations are too strong: pros and cons

Bainey K, Rossello X

free

Expert Review

10.4244/EIJ-D-24-01003 • Jul 7, 2025

Current and future applications of robotics in structural heart interventions

Chen X, Russo G, Chen M, Da Z, Pan X, Wang Y, Ho E, Votta E, Denti P, Tchétché D, Latib A, Taramasso M

free

Readers

Current issue